Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma

BMC Cancer

Table 3 Factors affecting the overall survival after hypofractionated radiotherapy

Variables	Univariate analysis			Multivariate analysis
Variables	HR	95% CI	P value	HR	95% CI	P value
Sex	1.05	0.60–1.83	0.876
Age	1.02	0.99–1.05	0.144	1.03	0.99–1.06	0.080
ECOG PS (0–1 vs. 2–3)	1.30	0.51–3.28	0.581
Tumor size	1.23	0.96–1.58	0.101	1.24	0.95–1.61	0.119
Alpha-fetoprotein (log₁₀)	1.24	0.92–1.67	0.154	1.17	0.86–1.59	0.323
Child-Pugh class	1.20	0.65–2.21	0.570
Number of previous treatment sessions	1.10	1.03–1.17	0.007	1.08	1.01–1.16	0.029
Dose (50 Gy vs. < 50 Gy)	1.03	0.98–1.08	0.310

HR hazard ratio, CI confidence interval, ECOG Eastern Cooperative Oncology Group, PS performance status

ISSN: 1471-2407